chr12-56471555-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_013267.4(GLS2):c.1741C>T(p.Leu581Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000886 in 1,614,206 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L581P) has been classified as Likely benign.
Frequency
Consequence
NM_013267.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GLS2 | NM_013267.4 | c.1741C>T | p.Leu581Phe | missense_variant | 18/18 | ENST00000311966.9 | |
SPRYD4 | NM_207344.4 | c.*1978G>A | 3_prime_UTR_variant | 2/2 | ENST00000338146.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GLS2 | ENST00000311966.9 | c.1741C>T | p.Leu581Phe | missense_variant | 18/18 | 1 | NM_013267.4 | P1 | |
SPRYD4 | ENST00000338146.7 | c.*1978G>A | 3_prime_UTR_variant | 2/2 | 1 | NM_207344.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000526 AC: 80AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000915 AC: 23AN: 251436Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135894
GnomAD4 exome AF: 0.0000438 AC: 64AN: 1461872Hom.: 0 Cov.: 32 AF XY: 0.0000468 AC XY: 34AN XY: 727234
GnomAD4 genome AF: 0.000519 AC: 79AN: 152334Hom.: 0 Cov.: 32 AF XY: 0.000416 AC XY: 31AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2021 | The c.1741C>T (p.L581F) alteration is located in exon 18 (coding exon 18) of the GLS2 gene. This alteration results from a C to T substitution at nucleotide position 1741, causing the leucine (L) at amino acid position 581 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at